Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2026-04-02 @ 10:13 AM
Study NCT ID:
NCT04466904
Status:
COMPLETED
Last Update Posted:
2021-07-23
First Post:
2020-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CIBI362A101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None